Schonfeld Strategic Advisors LLC Delcath Systems, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 42,094 shares of DCTH stock, worth $457,982. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,094
Previous 50,225
16.19%
Holding current value
$457,982
Previous $591,000
9.48%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DCTH
# of Institutions
116Shares Held
13.4MCall Options Held
79KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.61MShares$17.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$8.85 Million0.26% of portfolio
-
Vivo Capital, LLC Palo Alto, CA750KShares$8.16 Million2.59% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.65 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$6.06 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $93.5M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...